Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors
BRIEF-Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors June 8 (Reuters) - Ionis Pharmaceuticals Inc IONS.O:
IONIS ANNOUNCES APPOINTMENT OF LUDWIG HANTSON, PH.D. TO BOARD OF DIRECTORS
Source text: ID:nBw6m5BFwa
Further company coverage: IONS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study